Literature DB >> 9371655

Tyrosine phosphorylation of the herpes simplex virus type 1 regulatory protein ICP22 and a cellular protein which shares antigenic determinants with ICP22.

J A Blaho1, C S Zong, K A Mortimer.   

Abstract

At least eight herpes simplex virus type 1 (HSV-1) and five HSV-2 proteins were tyrosine phosphorylated in infected cells. The first viral tyrosine phosphoprotein identified was the HSV-1 regulatory protein ICP22. Also, two novel phosphotyrosine proteins were bound by anti-ICP22 antibodies. H(R22) is a cellular protein, while the F(R10) protein is observed only in HSV-1-infected cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371655      PMCID: PMC230299     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22.

Authors:  F C Purves; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Association of herpes simplex virus regulatory protein ICP22 with transcriptional complexes containing EAP, ICP4, RNA polymerase II, and viral DNA requires posttranslational modification by the U(L)13 proteinkinase.

Authors:  R Leopardi; P L Ward; W O Ogle; B Roizman
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; A Dolan; S Donald; F J Rixon
Journal:  J Mol Biol       Date:  1985-01-05       Impact factor: 5.469

4.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

5.  A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

Authors:  L E Post; B Roizman
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

6.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

7.  Guanylylation and adenylylation of the alpha regulatory proteins of herpes simplex virus require a viral beta or gamma function.

Authors:  J A Blaho; C Mitchell; B Roizman
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 8.  The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; M A Dalrymple; A J Davison; A Dolan; M C Frame; D McNab; L J Perry; J E Scott; P Taylor
Journal:  J Gen Virol       Date:  1988-07       Impact factor: 3.891

9.  Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice.

Authors:  A E Sears; I W Halliburton; B Meignier; S Silver; B Roizman
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

10.  Application of antibody to synthetic peptides for characterization of the intact and truncated alpha 22 protein specified by herpes simplex virus 1 and the R325 alpha 22- deletion mutant.

Authors:  M Ackermann; M Sarmiento; B Roizman
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

View more
  13 in total

1.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

2.  A truncation mutation of the neurovirulence ICP22 protein produced by a recombinant HSV-1 generated by bacterial artificial chromosome technology targets infected cell nuclei.

Authors:  Robert N Bowles; John A Blaho
Journal:  J Neurovirol       Date:  2011-12-03       Impact factor: 2.643

3.  Cell-type-specific tyrosine phosphorylation of the herpes simplex virus tegument protein VP11/12 encoded by gene UL46.

Authors:  George Zahariadis; Melany J Wagner; Rosalyn C Doepker; Jessica M Maciejko; Carly M Crider; Keith R Jerome; James R Smiley
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

4.  Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells.

Authors:  M Aubert; S A Rice; J A Blaho
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1.

Authors:  M Aubert; J O'Toole; J A Blaho
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection.

Authors:  L E Pomeranz; J A Blaho
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 7.  The herpes simplex virus type 1 infected cell protein 22.

Authors:  Fu-sen Lin; Qiong Ding; Hong Guo; Alan C Zheng
Journal:  Virol Sin       Date:  2010-02-12       Impact factor: 4.327

8.  Herpes simplex virus blocks apoptosis by precluding mitochondrial cytochrome c release independent of caspase activation in infected human epithelial cells.

Authors:  Martine Aubert; Lisa E Pomeranz; John A Blaho
Journal:  Apoptosis       Date:  2007-01       Impact factor: 4.677

9.  The major tegument structural protein VP22 targets areas of dispersed nucleolin and marginalized chromatin during productive herpes simplex virus 1 infection.

Authors:  María R López; Elisabeth F M Schlegel; Sandra Wintersteller; John A Blaho
Journal:  Virus Res       Date:  2008-06-12       Impact factor: 3.303

10.  Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts.

Authors:  Randall J Cohrs; Satish K Mehta; D Scott Schmid; Donald H Gilden; Duane L Pierson
Journal:  J Med Virol       Date:  2008-06       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.